At the 2023 Oracle Health Conference keynote, Valeos and Oracle announced their collaboration to address the challenges of the current organ transplant system through data and technology to drive better patient outcomes.
With more than 100,000 Americans awaiting transplant, and many others who never get listed, the U.S. organ transplant system is in desperate need of modernization — and Valeos is accelerating that transformation through connected data.
"During my emergency heart transplant journey in 2021, our family experienced firsthand that the transplant system needs vast improvements to better serve patients and donors," said Tristan Mace, Executive Chairman and Co-Founder of Valeos.
"Today, transplant data is siloed at hospitals, transplant centers, organ procurement organizations, and logistic companies, making collaboration difficult to provide patients with greater access to high-quality transplants, shorter waitlist times, longer life expectancy, and higher quality of life. Valeos is going to solve this problem."
The collaboration with Oracle Health marks a significant milestone to uniting transplant stakeholders through aggregated and longitudinal patient data.
Oracle is providing Valeos access to industry-leading expertise in electronic health records (EHRs), complex integrations, cloud infrastructure, security, and compliance.Watch the Announcement Learn about Valeos